Wide Ranks

LUCD

Lucid Diagnostics Inc.

1.00

Top Statistics
Market Cap 55 M Forward PE -1.85 Revenue Growth 49.70 %
Current Ratio 1.18 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -2.44 Enterprise / Revenue 25.33 Price To Sales Trailing12 Months 13.24
Profitability
Profit Margins 0.00 % Operating Margins -997.78 %
Balance Sheet
Total Cash 14 M Total Cash Per Share 0.2810 Total Debt 13 M
Total Debt To Equity 206.15 Current Ratio 1.18 Book Value Per Share -0.9610
All Measures
Short Ratio 68.00 % Message Board Id finmb_604709203 Shares Short Prior Month 1 M
Return On Equity -10.08 City New York Uuid 7080f4f7-4e2b-31a4-aea4-072f27668b0e
Previous Close 0.9984 First Trade Date Epoch Utc 1 B Book Value -0.9610
Total Debt 13 M Volume 292168 Fifty Two Week Low 0.6300
Total Cash Per Share 0.2810 Total Revenue 4 M Shares Short Previous Month Date 1 B
Target Median Price 2.75 Max Age 86400 Recommendation Mean 1.33
Sand P52 Week Change 0.3133 Operating Margins -997.78 % Target Mean Price 3.54
Net Income To Common -52314000 Short Percent Of Float 0.0144 Implied Shares Outstanding 55 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 589380
Average Volume10days 589380 Total Cash 14 M Next Fiscal Year End 1 B
Revenue Per Share 0.0900 Held Percent Insiders 0.5909 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 0.9984
Target Low Price 2.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 0.8937
Open 1.00 Free Cashflow -39469000 State NY
Dividend Yield 0.00 % Return On Assets -1.01 Time Zone Short Name EST
Trailing Eps -1.12 Day Low 0.9544 Address1 360 Madison Avenue
Shares Outstanding 55 M Price Hint 4 Target High Price 7.25
Website https://www.luciddx.com 52 Week Change -0.3243 Average Volume 323390
Forward Eps -0.6900 Recommendation Key strong_buy Compensation As Of Epoch Date 1 B
Quick Ratio 102.00 % Is_sp_500 False Regular Market Day High 1.00
Profit Margins 0.00 % Debt To Equity 206.15 Fifty Two Week High 1.58
Day High 1.00 Shares Short 293070 Regular Market Open 1.00
Industry Key medical-devices Earnings Growth 0.00 % Enterprise To Revenue 25.33
Revenue Growth 49.70 % Shares Percent Shares Out 0.0053 Operating Cashflow -44248000
Currency USD Time Zone Full Name America/New_York Market Cap 55 M
Is_nasdaq_100 False Zip 10017 Quote Type EQUITY
Industry Medical Devices Long Name Lucid Diagnostics Inc. Regular Market Day Low 0.9544
Held Percent Institutions 0.0418 Current Price 1.00 Address2 25th Floor
Enterprise To Ebitda -2.44 Financial Currency USD Current Ratio 1.18
Gross Margins -53.07 % Industry Disp Medical Devices Number Of Analyst Opinions 6
Country United States Float Shares 18 M Two Hundred Day Average 0.9058
Enterprise Value 106 M Price To Sales Trailing12 Months 13.24 Forward PE -1.85
Regular Market Volume 292168 Ebitda -43557000 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States.

The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma.

Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients.

The company was incorporated in 2018 and is based in New York, New York.

Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.